论文部分内容阅读
目的:对尿毒症高磷血症采用血液灌流进行治疗,对其治疗的效果进行分析和探讨。方法:我院在2012年11月～2013年1月期间,一共收治了83例尿毒症高磷血症患者。对这些患者采用血液灌流进行治疗。对患者治疗前后的血磷变化和并发症的情况进行对比和分析。结果:在对患者进行治疗之后,患者的血脂与治疗之前相比较,有明显的下降,差异显著,具有统计学意义(P<0.05)。结论:对尿毒症高磷血症患者采用血液灌流的方法进行治疗,效果显著,并且发生的并发症非常少,值得在临床上进行推广和使用。
Objective: To treat hemodialysis of uremic hyperphosphatemia and analyze the effect of treatment. Methods: In our hospital from November 2012 to January 2013, a total of 83 patients with uremic hyperphosphatemia were treated. These patients were treated with hemoperfusion. Before and after treatment of patients with changes in blood phosphorus and complications were compared and analyzed. Results: After the patients were treated, the blood lipids in patients were significantly lower than those before treatment, with significant difference (P <0.05). Conclusion: The treatment of patients with uremic hyperphosphatemia by hemoperfusion has a significant effect, and the occurrence of complications is very small, it is worth in the clinical promotion and use.